Brief Biography

Dr. Schwartz is an addiction psychiatrist and former director of the Division of Alcohol and Drug Abuse in the Department of Psychiatry at the University of Maryland School of Medicine.  His research interests include entry and engagement in drug abuse treatment, pharmacotherapy of opioid dependence, and health services research.  He is principal investigator of a National Institute on Drug Abuse funded study examining personal, community and program factors impacting upon drug abuse treatment entry and is co-investigator on several other NIDA-funded studies.  These include studies of methadone treatment as a re-entry strategy for heroin dependent prisoners, buprenorphine for re-entering prisoners in Puerto Rico and role induction as a means of engaging newly admitted patients treated with buprenorphine.  Dr. Schwartz serves as a co-investigator on the Mid-Atlantic Clinical Trials Network and is a member of the NIDA-F services research Initial Review Group.

Selected Publications
 

Schwartz, R.P., Highfield, D.A., Jaffe, J.H., Callaman, J.M., O’Grady, K.E., A randomized controlled trial of interim methadone maintenance: 10 month-follow-up. Drug and Alcohol Dependence, 86:30-36, 2007.

Schwartz, RP., McKenzie M., Rich J.D. Opioid addiction and incarceration: an overview. Medicine and Health/Rhode Island, 90, 157-158, 2007.

Kinlock, T.W., Gordon M.S., Schwartz, R.P., O’Grady, K.E., Fitzgerald T.T., Wilson, M. A randomized clinical trial of methadone maintenance for prisoners: Results at 1-month post-release. Drug and Alcohol Dependence, 91(2-3):220-7. 2007.

Highfield, D.A., Schwartz R.P., Jaffe, J.H., Callaman J., O’Grady K.E. Intravenous and intranasal heroin dependent treatment seekers: Similarities and differences. Addiction,102(11):1816-23, 2007.

Katz, E.C., Brown, B.S., Schwartz, R.P., King, S.D., Weintraub E, Barksdale W. Impact of role induction on long-term drug treatment outcomes. Journal of Addictive Diseases, 26, 81-90, 2007.

Albizu-Garcia, C., Caraballo Correa G., Hernandez Viver, A.D.,Kinlock, T.W., Gordon, M.S., Antron Avila, C., Colón Reyes, I., Schwartz R.P. Buprenorphine-Naloxone Treatment for Pre-release Opioid Dependent   Inmates in Puerto Rico. Journal of Addiction Medicine, 1(6): 126-132, 2007.

Kinlock TW, Gordon MS, Schwartz RP, O’Grady KE. A Study of Methadone Maintenance for Male Prisoners: 3-Month Postrelease Outcomes. Criminal Justice and Behavior 35, 34-47, 2007.

Schwartz RP, Kelly SM, O’Grady KE, Peterson JA, Reisinger HS, Mitchell SG, Wilson ME, Brown BS. In-treatment v. Out-of-treatment Opioid Dependent Adults: Drug Use and Criminal History. Am J Drug and Alcohol Abuse 34(1), 17-28, 2008.

Peterson J, Schacht Reisinger HS, Schwartz RP, Mitchell SG, Brown BS, Agar AH. (2008) Targeted Sampling in Drug Abuse Research:  A Review and Case Study. Field Methods, 20(2):155-170.

Schwartz RP, Kelly SM, O’Grady KE, Mitchell SG, Peterson JA, Reisinger HS, Agar MH, Brown BS. (2008) Attitudes toward buprenorphine and methadone among opioid-dependent individuals. American Journal on the Addictions, 17(5): 396 – 401.

Gordon MS, Kinlock TR, Schwartz RP, O’Grady KE. A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Findings at 6-Months Post-Release. Addiction. 103(8):1333-42.

Mitchell SG, Kelly SM, Brown BS, Reisinger HS, Peterson JA, Agar MH, Schwartz RP. Incarceration and opioid withdrawal: The experiences of methadone patients and out-of-treatment heroin users. Journal of Psychoactive Substance Abuse. In Press.

Reisinger HS, Schwartz RP, Mitchell SG, Peterson JA, Kelly SM, O’Grady KE, Marrari EA, Brown BS, Agar H. Premature Discharge from Methadone Treatment: Patient Perspectives, Journal of Psychoactive Substance Abuse.  In Press.

Kelly SM, Schwartz RP, O’Grady KE, Mitchell SG, Reisinger HS, Peterson JA,  Agar MH, Brown BS, (2009)  Gender differences among in- and out-of-treatment opioid-addicted individuals. Am J Drug and Alcohol Abuse, 35(1):38-42.

Katz EC, Schwartz RP, King SD, Highfield DA, O’Grady KE, Billings T, Gandhi D, W  Weintraub E, Glovinsky D, Barksdale W, Brown BS.(2009)  Brief v. extended buprenorphine detoxification in a community treatment program: Engagement and Short-Term Outcomes. Am J Drug and Alcohol Abuse, 35(2):63-7.

Peterson JA, Schwartz, RP, Mitchell SG, Reisinger HS, Kelly SM, O’Grady KE, Brown BS, Agar MH. Why don’t out-of-treatment individuals enter methadone treatment programs? International J Drug Policy, In Press.

Schwartz RP, Jaffe JH, O’Grady KE, Kinlock TW, Gordon MS, Kelly SM, Wilson ME, Ahmed A. Interim Methadone Treatment: Impact on Arrests. Drug and Alcohol Dependence, In Press.

Mitchell SG, Kelly SM, Barry BS, Reisinger HS, Peterson JA, Ruhf A, Agar MH, O’Grady KE, Schwartz RP Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland, American Journal on Addictions, In Press.

Kinlock TW, Gordon MS, Schwartz RP, Fitzgerald TT, O’Grady KE. A Randomized Clinical Trial of Methadone Maintenance for Prisoners: Results at Twelve-Months Post-Release, Journal of Substance Abuse Treatment. In Press.